Cargando…

Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma

BACKGROUND: Sorafenib has been approved in the indication of unresectable hepatocellular carcinoma, but there are many cases in which administration of the drug is discontinued due to severe side effects. In this study, we compared the characteristics of patients who continued and discontinued soraf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nojiri, Shunsuke, Kusakabe, Atsunori, Fujiwara, Kei, Shinkai, Noboru, Matsuura, Kentaro, Iio, Etsuko, Miyaki, Tomokatsu, Nomura, Tomoyuki, Sobue, Satoshi, Sano, Hitoshi, Hasegawa, Izumi, Ohno, Tomoyoshi, Takahashi, Yoshitsugu, Orito, Etsuro, Joh, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534393/ https://www.ncbi.nlm.nih.gov/pubmed/23293537 http://dx.doi.org/10.2147/CMAR.S38684

Ejemplares similares

Factors influencing distant recurrence of hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization therapy in patients with hepatitis C
por: Nojiri, Shunsuke, et al.
Publicado: (2011)

Influence of Genes Suppressing Interferon Effects in Peripheral Blood Mononuclear Cells during Triple Antiviral Therapy for Chronic Hepatitis C
por: Iijima, Sayuki, et al.
Publicado: (2015)

Characterization of hepatitis B virus with complex structural variations
por: Fujiwara, Kei, et al.
Publicado: (2018)

Novel Genetic Rearrangements Termed “Structural Variation Polymorphisms“ Contribute to the Genetic Diversity of Orthohepadnaviruses
por: Fujiwara, Kei, et al.
Publicado: (2019)

Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection
por: Suzuki, Takanori, et al.
Publicado: (2021)

Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib
por: Sakai, Kazuko, et al.
Publicado: (2015)

Complex structural variations in non-human primate hepatitis B virus
por: Nagura, Yoshihito, et al.
Publicado: (2021)

Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan
por: Nishikawa, Hiroki, et al.
Publicado: (2014)

Albumin Suppresses Human Hepatocellular Carcinoma Proliferation and the Cell Cycle
por: Nojiri, Shunsuke, et al.
Publicado: (2014)

Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy
por: Mizoshita, Tsutomu, et al.
Publicado: (2017)

Percutaneous Transhepatic Self-expanding Metallic Stent Placement for the Treatment of Malignant Afferent Loop Obstruction
por: Jinno, Naruomi, et al.
Publicado: (2017)

Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlapping Syndrome Complicated by Ulcerative Colitis
por: Suzuki, Takanori, et al.
Publicado: (2022)

Successful treatment of aortic dissection during sorafenib therapy for hepatocellular carcinoma
por: Tsuchiya, Atsunori, et al.
Publicado: (2018)

Nurse's difficulty and their educational needs regarding pediatric cancer care in Japan
por: Yoshitsugu, Mayu, et al.
Publicado: (2020)

Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Complete Response to Sorafenib Rechallenge in a Patient with Metastatic Renal Cell Carcinoma
por: Kasahara, Ryo, et al.
Publicado: (2017)

Successful treatment with sorafenib for sunitinib‐refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib
por: Morinaga, Ryota, et al.
Publicado: (2018)

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
por: Kudo, Masatoshi, et al.
Publicado: (2020)

Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
por: Karbownik, Agnieszka, et al.
Publicado: (2020)

Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib
por: Sanda, Mariko, et al.
Publicado: (2011)

Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
por: Kudo, Masatoshi, et al.
Publicado: (2022)

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
por: Ikeda, Atsuyuki, et al.
Publicado: (2021)

Rupture of a Small Hepatocellular Carcinoma in a Stable Disease State in a Patient Receiving Sorafenib Treatment
por: Tsuboi, Rumiko, et al.
Publicado: (2018)

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma
por: Takada, Hitomi, et al.
Publicado: (2018)

IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal
por: Okushin, Kazuya, et al.
Publicado: (2012)

Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C
por: Matsuura, Kentaro, et al.
Publicado: (2018)

Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo Infection
por: Hamada-Tsutsumi, Susumu, et al.
Publicado: (2015)

Caring Partnership within Newman's Theory of Health as Expanding Consciousness: Aiming for Patients to Find Meaning in Their Treatment Experiences
por: Imaizumi, Satoko, et al.
Publicado: (2021)

Ophthalmic viscosurgical device backflow into cartridge during intraocular lens insertion using injectors
por: Matsuura, Kazuki, et al.
Publicado: (2014)

Venom ophthalmia (keratoconjunctivitis) caused by nuchal gland secretion of Rhabdophis tigrinus: case report
por: Matsuura, Kazuki, et al.
Publicado: (2022)

Intraoperative Iodine Disinfection for Cataract Surgery [Letter]
por: Matsuura, Kazuki, et al.
Publicado: (2023)

Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib
por: Huh, Ki-Young, et al.
Publicado: (2021)

Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort
por: Trédan, Olivier, et al.
Publicado: (2023)

In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5′ splice sites
por: Sahashi, Kentaro, et al.
Publicado: (2007)

Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene
por: Watanabe, Tsunamasa, et al.
Publicado: (2013)

Effectiveness of Sorafenib in Hepatic Hemangioma
por: Tiwari, Prateek, et al.
Publicado: (2017)

Sorafenib as an Inhibitor of RUVBL2
por: Nano, Nardin, et al.
Publicado: (2020)

Sorafenib in Dupuytren and Ledderhose Disease
por: Schoenfeld, Joshua D, et al.
Publicado: (2022)

Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles
por: Watanabe, Takayuki, et al.
Publicado: (2020)

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial
por: Procopio, G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rht4n2i6s840beahem1hk8lm3h